CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yokoyama, T.
Right arrow Articles by Yoshimizu, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yokoyama, T.
Right arrow Articles by Yoshimizu, H.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 1227-1233, November 2003
© 2003 American Association for Cancer Research

Alcohol Flushing, Alcohol and Aldehyde Dehydrogenase Genotypes, and Risk for Esophageal Squamous Cell Carcinoma in Japanese Men

Tetsuji Yokoyama1, Akira Yokoyama2, Hoichi Kato3, Toshimasa Tsujinaka4, Manabu Muto5, Tai Omori6, Tatsumasa Haneda7, Yoshiya Kumagai8, Hiroyasu Igaki3, Masako Yokoyama9, Hiroshi Watanabe10 and Haruko Yoshimizu2

1 Department of Technology Assessment and Biostatistics, National Institute of Public Health, Saitama, Japan; 2 National Institute on Alcoholism, Kurihama National Hospital, Kanagawa, Japan; 3 Surgery Division, National Cancer Center Hospital, Tokyo, Japan; 4 Department of Surgery, National Osaka Hospital, Osaka, Japan; 5 Internal Medicine Division, National Cancer Center Hospital East, Chiba, Japan; 6 Department of Surgery, Kawasaki Municipal Hospital, Kanagawa, Japan; 7 Kamio Memorial Hospital, Tokyo, Japan; 8 Kumagai Satellite Clinic, Tokyo, Japan; 9 Mitsukoshi Health and Welfare Foundation, Tokyo, Japan; and 10 Department of Surgery, School of Medicine, Keio University, Tokyo, Japan

Alcohol flushing after light drinking is triggered mainly by severe acetaldehydemia in individuals possessing inactive aldehyde dehydrogenase (ALDH)-2. Inactive ALDH2 encoded by ALDH2*1/2*2 and the low-activity form of alcohol dehydrogenase (ADH)-2 encoded by ADH2*1/2*1 enhance the risk for esophageal cancer in Japanese light to heavy drinkers, a significant association that emphasizes the importance of screening tests for inactive ALDH2 based on alcohol flushing. The objectives of the present report were (a) to evaluate the reliability of a simple questionnaire that asks about both current and past flushing for detecting inactive ALDH2 and (b) to predict cancer risk based on flushing in a case-control manner. The study subjects consisted of 233 Japanese men with esophageal squamous cell carcinoma and 610 cancer-free Japanese men. When current or former flushing individuals were considered to have inactive ALDH2, the sensitivity and specificity of the test were 84.8% and 82.3%,, respectively, for the cases and 90.1% and 88.0%, respectively, for the controls. To clarify the characteristics of men who had genetically inactive ALDH2 but did not report alcohol flushing, we analyzed individuals possessing the ALDH2*1/2*2 genotype and found that those who also had ADH2*1/2*1 (both cases and controls) tended not to report current flushing, and those who did not report current flushing (controls only) tended to be heavier drinkers. As compared with overall never or rare drinking, the cancer risks for light (1–8.9 units/week; 1 unit = 22 g of ethanol), moderate (9–17.9 units/week), and heavy (18+ units/week) drinkers with current or former flushing (odds ratio = 6.69, 42.66, and 72.86, respectively) significantly exceeded the risks for those who had never flushed (odds ratio = 1.27, 10.12, and 15.61, respectively), even after adjustment for age, smoking, and diet. The flushing questionnaire may be used in large-scale epidemiological studies as a surrogate marker of ALDH2 genotype to predict individual cancer risk.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
T. Asakage, A. Yokoyama, T. Haneda, M. Yamazaki, M. Muto, T. Yokoyama, H. Kato, H. Igaki, T. Tsujinaka, Y. Kumagai, et al.
Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma
Carcinogenesis, April 1, 2007; 28(4): 865 - 874.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Yokoyama, T. Omori, T. Yokoyama, Y. Sato, T. Mizukami, S. Matsushita, S. Higuchi, K. Maruyama, H. Ishii, and T. Hibi
Risk of Squamous Cell Carcinoma of the Upper Aerodigestive Tract in Cancer-Free Alcoholic Japanese Men: An Endoscopic Follow-up Study.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2209 - 2215.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.